Global Infectious Disease Diagnostics Market Size & Trends Report Segmented by Product and Service (Instruments, Reagents, Kits, Software), Disease Type (HIV, Hepatitis, TB, HAIs, Influenza), End User (Hospitals/Clinics, Diagnostic Laboratories) & Regional Forecast to 2030

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2025-2026)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Infectious Disease Diagnostics Marke"4">
    • Market Overview
      • Market Dynamics
        • Drivers
          • Increasing prevalence of infectious diseases
          • Growing threat of emerging infectious diseases
          • Rise in demand for point-of-care testing
          • Technological advancements
          • Rising awareness and initiatives to control infectious diseases spread
          • Increasing concerns about antimicrobial resistance
        • Restraints
          • High cost of advanced diagnostic tools
          • Lack of infrastructure in developing regions
          • Regulatory and reimbursement challenges
          • Limited accuracy of some rapid tests
        • Opportunities
          • Emerging markets and untapped regions
          • Integration of digital health and diagnostics
          • Growing shift towards molecular diagnostics
          • Growing demand for point-of-care (POC) and rapid testing
        • Key Market Trends
          • Rise in home-based and self-testing kits
        • Unmet Market Needs
        • Industry Speaks
    • "5">
    • Global Infectious Disease Diagnostics Market Size & Forecast (2023-2030), By Product and Service, USD Million
      • Introduction
      • Instruments
      • Reagents, Kits and Consumables
      • Software and Services
    • Global Infectious Disease Diagnostics Market Size & Forecast (2023-2030), By Testing Type, USD Million
      • Introduction
      • Laboratory Testing
      • POC Testing
    • Global Infectious Disease Diagnostics Market Size & Forecast (2023-2030), By Sample Type, USD Million
      • Introduction
      • Blood, Serum, and Plasma
      • Urine
      • Others
    • Global Infectious Disease Diagnostics Market Size & Forecast (2023-2030), By Technology, USD Million
      • Introductiostics
      • Molecular Diagnostics
      • Microbiology
      • Others
    • Global Infectious Disease Diagnostics Market Size & Forecast (2023-2030), By Disease Type, USD Million
      • Introduction
      • Hepatitis
      • Tuberculosis (TB)
      • Sexually Transmitted Infections
      • Hospital-Acquired Infections (HAIs)
      • Influenza
      • Others
    • Global Infectious Disease Diagnostics Market Size & Forecast (2023-2030), By End User, USD Million
      • Introduction
      • Hospitals & Clinics
      • Diagnostic Laboratories
      • Academic & Research Institutes
      • Others
    • Global Infectious Disease Diagnostics Market Size & Forecast (2023-2030), By Region, USD Million
      • Introduction
      • North America Infectious Disease Diagnosticsast (2023-2030), By Country, USD Million
        • US
          • Market Size & Forecast, By Product and Service (USD Million)
          • Market Size & Forecast, By Testing Type (USD Million)
          • Market Size & Forecast, By Sample Type (USD Million)
          • Market Size & Forecast, By Technology (USD Million)
          • Market Size & Forecast, By Disease Type (USD Million)
          • Market Size & Forecast, By End User (USD Million)
        • Canada
          • Market Size & Forecast, By Product and Service (USD Million)
          • Market Size & Forecast, By Testing Type (USD Million)
          • Market Size & Forecast, By Sample Type (USD Million)
          • Market Size & Forecast, By Technology (USD Million)
          • Market Size & Forecast, By Disease Type (USD Million)
          • Market Size & Forecast, By End User (USD Million)
          • SD Million
            • UK
              • Market Size & Forecast, By Product and Service (USD Million)
              • Market Size & Forecast, By Testing Type (USD Million)
              • Market Size & Forecast, By Sample Type (USD Million)
              • Market Size & Forecast, By Technology (USD Million)
              • Market Size & Forecast, By Disease Type (USD Million)
              • Market Size & Forecast, By End User (USD Million)
            • Germany
              • Market Size & Forecast, By Product and Service (USD Million)
              • Market Size & Forecast, By Testing Type (USD Million)
              • Market Size & Forecast, By Sample Type (USD Million)
              • Market Size & Forecast, By Technology (USD Million)
              • Market Size & Forecast, By Disease Type (USD Million)
              • Market Size & Forecast, By End User (USD Million)
            • France g Type (USD Million)
            • Market Size & Forecast, By Sample Type (USD Million)
            • Market Size & Forecast, By Technology (USD Million)
            • Market Size & Forecast, By Disease Type (USD Million)
            • Market Size & Forecast, By End User (USD Million)
          • Italy
            • Market Size & Forecast, By Product and Service (USD Million)
            • Market Size & Forecast, By Testing Type (USD Million)
            • Market Size & Forecast, By Sample Type (USD Million)
            • Market Size & Forecast, By Technology (USD Million)
            • Market Size & Forecast, By Disease Type (USD Million)
            • Market Size & Forecast, By End User (USD Million)
          • Spain
            • Market Size & Forecast, By Product and Service (USD Million)
            • Market Size & Forecast, By Testing Type (USD Million)
            • Market Size & Forecast, By Disease Type (USD Million)
            • Market Size & Forecast, By End User (USD Million)
          • Rest of Europe
            • Market Size & Forecast, By Product and Service (USD Million)
            • Market Size & Forecast, By Testing Type (USD Million)
            • Market Size & Forecast, By Sample Type (USD Million)
            • Market Size & Forecast, By Technology (USD Million)
            • Market Size & Forecast, By Disease Type (USD Million)
            • Market Size & Forecast, By End User (USD Million)
        • Asia Pacific (APAC) Infectious Disease Diagnostics Market Size & Forecast (2023-2030), By Country, USD Million
          • China
            • Market Size & Forecast, By Product and Service (USD Million)
            • Market Size & Forecast, By Testing Type (USD Million)
            • Market Size
            • Market Size & Forecast, By Disease Type (USD Million)
            • Market Size & Forecast, By End User (USD Million)
          • Japan
            • Market Size & Forecast, By Product and Service (USD Million)
            • Market Size & Forecast, By Testing Type (USD Million)
            • Market Size & Forecast, By Sample Type (USD Million)
            • Market Size & Forecast, By Technology (USD Million)
            • Market Size & Forecast, By Disease Type (USD Million)
            • Market Size & Forecast, By End User (USD Million)
          • India
            • Market Size & Forecast, By Product and Service (USD Million)
            • Market Size & Forecast, By Testing Type (USD Million)
            • Market Size & Forecast, By Sample Type (USD Million)
            • Market Size & Forecast, By Technology (USD Million)
            • Market Size & Forecast,
            • Rest of Asia Pacific
              • Market Size & Forecast, By Product and Service (USD Million)
              • Market Size & Forecast, By Testing Type (USD Million)
              • Market Size & Forecast, By Sample Type (USD Million)
              • Market Size & Forecast, By Technology (USD Million)
              • Market Size & Forecast, By Disease Type (USD Million)
              • Market Size & Forecast, By End User (USD Million)
          • Latin America (LATAM) Infectious Disease Diagnostics Market Size & Forecast (2023-2030), USD Million
            • Market Size & Forecast, By Product and Service (USD Million)
            • Market Size & Forecast, By Testing Type (USD Million)
            • Market Size & Forecast, By Sample Type (USD Million)
            • Market Size & Forecast, By Technology (USD Million)
            • Market Size & Forecast, By Disease Type (USD Million)
            • Market Size & Forecast, By Product and Service (USD Million)
            • Market Size & Forecast, By Testing Type (USD Million)
            • Market Size & Forecast, By Sample Type (USD Million)
            • Market Size & Forecast, By Technology (USD Million)
            • Market Size & Forecast, By Disease Type (USD Million)
            • Market Size & Forecast, By End User (USD Million"12">
            • Competitive Landscape
              • Key Players and their Competitive Positioning
                • Key Player Comparison
                • Segment-wise Player Mapping
                • Market Share Analysis (2024)
                • Company Categorization Matrix
                  • Dominants/Leaders
                  • New Entrants
                  • Emerging Players
                  • Innovative Players
                • Key Strategies Assessment, By Player (2022-2025)
                  • New Product and Service Launches
                  • Partnerships, Agreements, & Collaborations
                  • Mergers & Acquisitions
                  • Geographic Expansion
  1. Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

  • Hoffmann-La Roche Ltd
  • Abbott
  • Biomrieux
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • DH Life Sciences, LLC
  • BD (Becton, Dickinson and Company)
  • Hologic, Inc.
  • Qiagen
  • Revvity
  • Other Prominent Players

Note: *Indicative list

**For listed companies